Correction to “Novel Indoleamine-2,3-dioxygenase-Targeted Pt(IV) Prodrugs Regulate the Tumor Immune Microenvironment to Achieve Chemoimmunotherapy In Vitro and In Vivo”

Abstract

Replace the error image in Figure 3(a) with the original, correctly labeled data set for compound 10 (24 h treatment). The original image used in this panel was inadvertently incorrect due to a technical oversight during figure assembly. This error does not impact the scientific conclusions of our study, nor does it undermine its reproducibility. We sincerely apologize for this oversight and are committed to taking full responsibility for maintaining the accuracy of all our published work. The correct version of Figure 3 is shown below. Figure 3. (a) Migration inhibition on HeLa cells by compounds at 0.1 μM after 24 h treatment. (b) Invasion suppression on HeLa cell by compounds at 0.1 μM after 24 h treatment. (c) Statistical analysis of cell mobility. (d) Statistical analysis of cell invasion. ***P < 0.001, compared with control group. This article has not yet been cited by other publications.